Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    11129744 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
Condition: Alzheimer Disease
Interventions: Drug: Cerebrolysin;   Drug: Donepezil

Study has passed its completion date and status has not been verified in more than two years.